Status:
UNKNOWN
Clinical Decision Support Tool for Improving the Adequacy of Anticoagulant Therapy in Non-valvular Atrial Fibrillation
Lead Sponsor:
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Collaborating Sponsors:
Institut Català de la Salut
Department of Health, Generalitat de Catalunya
Conditions:
Atrial Fibrillation
Anticoagulants
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Atrial fibrillation (AF) is the most common cardiac arrhythmia and increases the risk of ischemic stroke 4-5-fold. The prevention of complications is based on oral or antiplatelet anticoagulant treatm...
Eligibility Criteria
Inclusion
- Inclusion Criteria (all criteria must be met):
- Patients diagnosed with NVAF one year prior to the implementation of the computerized tool;
- Patients receiving anticoagulant treatment with DOACs or VKAs;
- Patients followed in primary care (with at least 6 INR controls during the year prior to the intervention).
- Exclusion Criteria:
- Patients with INR control in the reference hospital;
- patients with valvular AF (mitral stenosis);
- patients with a prosthetic heart valve;
- change to another primary care center.
Exclusion
Key Trial Info
Start Date :
December 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2019
Estimated Enrollment :
63001 Patients enrolled
Trial Details
Trial ID
NCT03367325
Start Date
December 15 2017
End Date
December 15 2019
Last Update
December 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
Barcelona, Spain, 08007